Exploring the inhibitory effects of liquiritigenin against tau fibrillation and related neurotoxicity as a model of preventive care in Alzheimer’s disease
Abstract
Aggregation of tau protein into the form of insoluble amyloid fibrils is linked with Alzheimer's disease. The identification of potential small molecules that can inhibit tau protein from undergoing aggregation has received a great deal of interest, recently. In the present study, the possible inhibitory effects of liquiritigenin as a member of chiral flavanone family on tau amyloid fibrils formation and their resulting neurotoxicity were assessed by different biophysical and cellular assays. The inhibitory effect of the liquiritigenin against tau amyloid formation was investigated using thioflavin T (ThT) and 1-Anilino-8-naphthalene sulfonate (ANS) fluorescence spectroscopy, Congo red (CR) binding assays, transmission electron microscopy (TEM) analysis, and circular dichroism (CD) spectroscopy. Neurotoxicity assays were also performed against neuron-like cells (SH-SY5Y) using 3-(4,5-Dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT) reduction, reactive oxygen species (ROS), catalase (CAT) and caspase-3 activity measurements. We found that liquiritigenin served as an efficient inhibitor of tau amyloid fibrils formation through prevention of structural transition in tau structure, exposure of hydrophobic patches and their associated neurotoxicity mediated by decrease in the production of ROS and caspase-3 activity and elevation of CAT activity. These data may finally find applications in the development of promising inhibitors against amyloid fibril formation and treatment of Alzheimer's disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Liquiritigenin stops formation of tau amyloid fibrils with fewer cytotoxic effects.
“The researchers revealed that liquiritigenin could stop the formation of tau amyloid fibrils in a way that exhibits fewer cytotoxic effects.”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [119]
Glycyrrhiza crude extract, active phytoconstituents, and derivatives exhibit anti-Alzheimer's potential by inhibiting pTau and Aβ.
“Glycyrrhiza crude extract, active phytoconstituents, and their derivatives have been reported to exhibit an excellent anti-AD potential by acting on different events of AD, for instance, inhibition of pTau and Aβ inhibition.”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [119]
Cites
1 retracted
Meng, F.-C., & Lin, J.-K. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15185747911701 · Cited by 43 · see citing works
RetractedThe projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,668 · see citing works
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506 · see citing works
Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue
Lu, J., Qiang, W., Yau, W., Schwieters, C. D., Meredith, S. C., & Tycko, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.035 · Cited by 1,087 · see citing works
Porat, Y., Abramowitz, A., & Gazit, E. (2005) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 994 · see citing works
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Kametani, F., & Hasegawa, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00025 · Cited by 836 · see citing works
Mechanism of thioflavin T binding to amyloid fibrils
Khurana, R., Coleman, C., Ionescu‐Zanetti, C., Carter, S. A., Krishna, V., Grover, R. K., Roy, R., & Singh, S. S. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.06.006 · Cited by 833 · see citing works
Bioavailability of bioactive food compounds: a challenging journey to bioefficacy.
Rein, M. J., Renouf, M., Cruz-Hernandez, C., Actis-Goretta, L., Thakkar, S. K., & Pinto, M. I. D. S. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04425.x · Cited by 763 · see citing works
Review on Alzheimer’s Disease: Inhibition of Amyloid Beta and Tau Tangle Formation
Ashrafian, H., Zadeh, E. H., & Khan, R. H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.192 · Cited by 368 · see citing works
Inhibition of protein aggregation and amyloid formation by small molecules
Doig, A. J., & Derreumaux, P. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.12.004 · Cited by 295 · see citing works
Development of tau aggregation inhibitors for alzheimer's disease
Bulic, B., Pickhardt, M., Schmidt, B., Mandelkow, E., Waldmann, H., & Mandelkow, E. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802621 · Cited by 286 · see citing works
Ferruzzi, M. G., Lobo, J., Janle, E. M., Cooper, B. R., Simon, J. E., Wu, Q., Welch, C., Ho, L., Weaver, C. M., & Pasinetti, G. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1135 · Cited by 250 · see citing works
Kawahara, M., & Kuroda, Y. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00370-1 · Cited by 221 · see citing works
Wang, S., Wang, Y., Su, Y., Zhou, W., Yang, S., Zhang, R., Zhao, M., Li, Y., Zhang, Z., Zhan, D., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.03.003 · Cited by 221 · see citing works
Natural product-based amyloid inhibitors
Velander, P., Wu, L., Henderson, F. E., Zhang, S., Bevan, D. R., & Xu, B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.004 · Cited by 203 · see citing works
Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry
Mohamed, T., Shakeri, A., & Rao, P. P. N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.049 · Cited by 181 · see citing works
Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases
Alam, P., Chaturvedi, S. K., Siddiqi, M. K., Rajpoot, R. K., Ajmal, M. R., Zaman, M., & Khan, R. H. (2016) · Scientific Reports · doi:10.1038/srep26759 · Cited by 177 · see citing works
Ghag, G., Bhatt, N. N., Cantu, D. V., Guerrero‐Munoz, M. J., Ellsworth, A., Sengupta, U., & Kayed, R. (2018) · Protein Science · doi:10.1002/pro.3499 · Cited by 157 · see citing works
Tsai, Y.-M., Jan, W.-C., Chien, C.-F., Lee, W.-C., Lin, L.-C., & Tsai, T. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.01.059 · Cited by 147 · see citing works
Lewis, H. D., Beher, D., Cookson, N., Oakley, A. E., Piggott, M. A., Morris, C. M., Jaros, E., Perry, R., Ince, P. G., Kenny, R. A., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00696.x · Cited by 143 · see citing works
Regitz, C., Dußling, L. M., & Wenzel, U. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400014 · Cited by 142 · see citing works
Re, F., Airoldi, C., Zona, C., Masserini, M., Ferla, B. L., Quattrocchi, N., & Nicotra, F. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791959729 · Cited by 139 · see citing works
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease
Gadhave, K., Bolshette, N. B., Ahire, A., Pardeshi, R., Thakur, K. K., Trandafir, C.-M., Istrate, A., Ahmed, S., Lahkar, M., Muresanu, D. F., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12817 · Cited by 119 · see citing works
Protonation favors aggregation of lysozyme with SDS
Khan, J. M., Chaturvedi, S. K., Rahman, S. K., Ishtikhar, M., Qadeer, A., Ahmad, E., & Khan, R. H. (2014) · Soft Matter · doi:10.1039/c3sm52435c · Cited by 115 · see citing works
The Surfactant-Induced Conformational and Activity Alterations in Rhizopus niveus Lipase
Alam, P., Rabbani, G., Badr, G., Badr, B. M., & Khan, R. H. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0329-2 · Cited by 108 · see citing works
Shen, Y., Ye, B., Chen, P., Wang, Q., Fan, C., Shu, Y., & Xiang, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00394 · Cited by 105 · see citing works
Soto-Ortega, D. D., Murphy, B. P., Gonzalez‐Velasquez, F. J., Wilson, K. A., Xie, F., Wang, Q., & Moss, M. A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.010 · Cited by 104 · see citing works
The Effect of Milk Protein on the Bioavailability of Cocoa Polyphenols
Keogh, J. B., McInerney, J. K., & Clifton, P. M. (2007) · Journal of Food Science · doi:10.1111/j.1750-3841.2007.00314.x · Cited by 104 · see citing works
Zeinabad, H. A., Kachooei, E., Saboury, A. A., Kostova, I. P., Attar, F., Vaezzadeh, M., & Falahati, M. (2016) · RSC Advances · doi:10.1039/c6ra16422f · Cited by 104 · see citing works
Ndam, V. N., Schluesener, J. K., Moundipa, P. F., & Schluesener, H. J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400290 · Cited by 103 · see citing works
Characterization of a partially folded intermediate of stem bromelain at low pH
Haq, S. K., Rasheedi, S., & Khan, R. H. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2002.02620.x · Cited by 98 · see citing works
Structure and Mechanism of Action of Tau Aggregation Inhibitors
Cisek, K. K., Cooper, G., Huseby, C. J., & Kuret, J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141107150331 · Cited by 97 · see citing works
Role of aromatic amino acids in amyloid self-assembly
Stanković, I. M., Niu, S., Hall, M. B., & Zarić, S. D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.064 · Cited by 94 · see citing works
Small molecule probes of protein aggregation
Young, L. M., Ashcroft, A. E., & Radford, S. E. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.06.008 · Cited by 93 · see citing works
Zhu, X., Shi, J., & Li, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.045 · Cited by 88 · see citing works
Do, T. D., Economou, N. J., Chamas, A., Buratto, S. K., Shea, J., & Bowers, M. T. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506258g · Cited by 81 · see citing works
Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies
Zheng, Q., Kebede, M. T., Kemeh, M. M., Islam, S., Lee, B., Bleck, S. D., Wurfl, L. A., & Lazo, N. D. (2019) · Molecules · doi:10.3390/molecules24122316 · Cited by 81 · see citing works
Myricetin Prevents Fibrillogenesis of Hen Egg White Lysozyme
He, J., Wang, Y., Chang, A. K., Xu, L., Wang, N., Chong, X., Li, H., Zhang, B., Jones, G. W., & Song, Y. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5025449 · Cited by 68 · see citing works
Lo, C. H., Lim, C. K., Ding, Z., Wickramasinghe, S. P., Braun, A. R., Ashe, K. H., Rhoades, E. R., Thomas, D. D., & Sachs, J. N. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.4954 · Cited by 65 · see citing works
Pickhardt, M., Neumann, T., Schwizer, D., Callaway, K., Vendruscolo, M., Schenk, D., George‐Hyslop, P. S., Mandelkow, E., Dobson, C. M., McConlogue, L., et al. (2015) · Current Alzheimer Research · doi:10.2174/156720501209151019104951 · Cited by 63 · see citing works
The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies
Goedert, M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.001 · Cited by 62 · see citing works
Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity
Zand, Z., Khaki, P. A., Salihi, A. B., Sharifi, M., Nanakali, N. M. Q., Al-Asady, A. A., Aziz, F. M., Shahpasand, K., Hasan, A., & Falahati, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s220380 · Cited by 62 · see citing works
McManus, M. J., Murphy, M. P., & Franklin, J. L. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.09.002 · Cited by 55 · see citing works
Brahmachari, S., Paul, A., Segal, D., & Gazit, E. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0026 · Cited by 52 · see citing works
Modulating disease-relevant tau oligomeric strains by small molecules
Cascio, F. L., García, S., Montalbano, M., Puangmalai, N., McAllen, S., Pace, A., Piccionello, A. P., & Kayed, R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014630 · Cited by 51 · see citing works
Liang, F., Zhang, H., Gao, H., Cheng, D., Zhang, N., Du, J., Yue, J., Du, P., Zhao, B., & Yin, L. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220957255 · Cited by 48 · see citing works
Du, Y., Luo, M., Du, Y., Xu, M., Yao, Q., Wang, K., & He, G. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00284-z · Cited by 47 · see citing works
Structural Determinants of Tau Aggregation Inhibitor Potency
Schafer, K. N., Cisek, K. K., Huseby, C. J., Chang, E. S., & Kuret, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503474 · Cited by 43 · see citing works
Bijari, N., Balalaie, S., Akbari, V., Golmohammadi, F., Moradi, S., Adibi, H., & Khodarahmi, R. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.175 · Cited by 43 · see citing works
Saini, R. K., Shuaib, S., Goyal, D., & Goyal, B. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1511475 · Cited by 43 · see citing works
Liu, R. T., Zou, L. B., Fu, J. Y., & Lu, Q. J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.041 · Cited by 42 · see citing works
Azure C Targets and Modulates Toxic Tau Oligomers
Cascio, F. L., & Kayed, R. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00501 · Cited by 40 · see citing works
Gilan, S. S. T., Rayat, D. Y., Mustafa, T. A., Aziz, F. M., Shahpasand, K., Akhtari, K., Salihi, A. B., Abou‐Zied, O. K., & Falahati, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s212387 · Cited by 36 · see citing works
Liquiritigenin Reduces Blood Glucose Level and Bone Adverse Effects in Hyperglycemic Adult Zebrafish
Carnovali, M., Luzi, L., Terruzzi, I. M., Banfi, G., & Mariotti, M. (2019) · Nutrients · doi:10.3390/nu11051042 · Cited by 31 · see citing works
Akbari, V., Ghobadi, S., Mohammadi, S., & Khodarahmi, R. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108218 · Cited by 31 · see citing works
Kotani, R., Urano, Y., Sugimoto, H., & Noguchi, N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160794 · Cited by 29 · see citing works
Zhao, C., Liu, Y., Cong, D., Zhang, H., Yu, J., Jiang, Y., Cui, X., & Sun, J. (2013) · Biomedical Chromatography · doi:10.1002/bmc.2970 · Cited by 28 · see citing works
Khodabandeh, A., Yakhchian, R., Hasan, A., Paray, B. A., Shahi, F., Rasti, B., Mirpour, M., Sharifi, M., Derakhshankhah, H., Akhtari, K., et al. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113198 · Cited by 28 · see citing works
Ortho-methylated 3-hydroxypyridines hinder hen egg-white lysozyme fibrillogenesis
Mariño, L., Pauwels, K., Casasnovas, R., Sanchís, P., Vilanova, B., Muñoz, F., Donoso, J., & Adrover, M. (2015) · Scientific Reports · doi:10.1038/srep12052 · Cited by 27 · see citing works
Wang, P., Cascio, F. L., Gao, J., Kayed, R., & Huang, X. (2018) · Chemical Communications · doi:10.1039/c8cc05072d · Cited by 23 · see citing works
Stanković, I. M., Filipović, J. P. B., & Zarić, S. D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.251 · Cited by 19 · see citing works
Zaman, M., Zakariya, S. M., Nusrat, S., Chandel, T. I., Meeran, S. M., Ajmal, M. R., Alam, P., Wahiduzzaman, & Khan, R. H. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.083 · Cited by 18 · see citing works
Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice
Sayre, C., Alrushaid, S., Davies, N., & Martinez, S. (2016) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.192484 · Cited by 17 · see citing works
Inhibition of tau aggregation and associated cytotoxicity on neuron-like cells by calycosin
Zhang, Z., Min, L., Peikui, Y., Chen, Z., Liu, Y., Junli, W., Fenlian, Y., & Zheng, Y. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.030 · Cited by 16 · see citing works
Chiral analytical method development of liquiritigenin with application to a pharmacokinetic study
Sayre, C. L., Hopkins, M. M., Takemoto, J. K., & Davies, N. M. (2012) · Biomedical Chromatography · doi:10.1002/bmc.2787 · Cited by 11 · see citing works
Monteiro, K. L. C., Alcântara, M. G. D. S., de Aquino, T. M., & da Silva‐Júnior, E. F. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200414164038 · Cited by 10 · see citing works
Flagged first, then by citations
1 of the 67 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040053 · Cited by 61 · see citing works
Sedov, I. A., & Khaibrakhmanova, D. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113428 · Cited by 48 · see citing works
Ticinesi, A., Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Rio, D. D., Ventura, M., Sgoifo, A., & Angelino, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215493 · Cited by 40 · see citing works
Research progress of natural products and their derivatives against Alzheimer’s disease
Liu, J., Guo, H., Quan, Z., Shen, Q., Cui, H., & Li, X. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2171026 · Cited by 36 · see citing works
Qin, H., Song, Z., Zhao, C., Yang, J., Xia, F., Wang, L., Ali, A., & Zheng, W. (2022) · Nutrients · doi:10.3390/nu14061287 · Cited by 23 · see citing works
Anbaraki, A., Dindar, Z., Mousavi-Jarrahi, Z., Ghasemi, A., Moeini, Z., Evini, M., Saboury, A. A., & Seyedarabi, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132401 · Cited by 13 · see citing works
Tang, Z., Sha, T., Wang, Y., Xiao, Y. C., Ding, Y., Ni, R., & Qi, X. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123759 · Cited by 12 · see citing works
Gasymov, O. K., Mammedzade, A. M., Bakhishova, M. J., Guliyeva, A. J., Ragona, L., & Molinari, H. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106680 · Cited by 7 · see citing works
Neuroactive Phytoconstituents of Glycyrrhiza glabra for the Treatment of Alzheimer’s Disease
Verma, M., Usman, M., & Singh, N. K. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266357793241223100307 · Cited by 7 · see citing works
Luo, L., Pan, Y., Chen, F., & Zhang, Z. (2024) · Medicine · doi:10.1097/md.0000000000040726 · Cited by 6 · see citing works
Yin, H., Han, Y.-L., Yan, X. H., & Guan, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126140 · Cited by 6 · see citing works
Rasoulian, M., Anbaraki, A., Mousavi-Jarrahi, Z., Ghasemi, A., Absalan, M., Motevaseli, E., Shafizadeh, M., Ahmadian, S., Saboury, A. A., & Seyedarabi, A. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.139177 · Cited by 5 · see citing works
Mishra, A. K., Mishra, A., Kamal, Y. T., Kumar, A., Singh, H., Verma, S., & Khan, G. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100877 · Cited by 4 · see citing works
Deng, Y. L., Chen, C., Li, H., Wang, T., Zhang, X., Wang, X., & Pan, G. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266347052250407110353 · Cited by 3 · see citing works
OGT Binding Peptide-Tagged Strategy Increases Protein O-GlcNAcylation Level in E. coli
Li, Y., Yang, Z., Jia, C., Chen, Y., Jiang, C., Zhong, T., Su, Y., Liang, Y., & Sun, H. Z. (2023) · Molecules · doi:10.3390/molecules28052129 · Cited by 3 · see citing works
Osthole's capacity to prevent tau aggregation, a key protein in tauopathy and Alzheimer's disease
Liu, W., Xu, H., Wang, C., Geng, G., Yang, Y., & Chen, G. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143235 · Cited by 3 · see citing works
Wagdy, M., Ibrahim, A. A., Yahia, A. M., Maher, R. M., Abo-Elwafa, A. H., Salah, A., & Heikal, Y. M. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578821 · Cited by 2 · see citing works
Hedna, R., Relave, E. T., Robin, M., Kovacic, H., & Breuzard, G. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100309 · Cited by 1 · see citing works
Chirality-engineered nanomaterials for biomedical applications
Huang, Z., Zhou, H., Zhang, S., Song, S., Feng, C., Ke, Z., Tang, J., & Dai, Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115015 · Cited by 1 · see citing works
Luo, L., Pan, Y., Chen, F., & Zhang, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4225413/v1
Ugwah-Oguejiofor, C. J., Okechukwu, P. N., Mathias, S. N., Ofokansi, M. N., & Janakiraman, A. K. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-49144-3.00007-1
Verma, K., Chatterjee, K. M., Raha, T., Basak, S., & Patel, T. (2026) · Studies in Rhythm Engineering · doi:10.1007/978-3-032-20634-3_7
- Authors
- Yuan, X., Wang, Z., Zhang, L., Sui, R., & Khan, S.
- Affiliations
- Jinzhou Medical University (CN)
- Second Affiliated Hospital of Zhengzhou University (CN)
- Corresponding author
- Sui, Rubo
- Khan, Suliman
- Venue
- International Journal of Biological Macromolecules
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 183
- Pages
- 1184-1190
- ISSN
- 0141-8130 (ISSN-L)
- OpenAlex
- W3157536360
- Cited by
- 22
- References
- 67
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 1
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Journal of Biological Macromolecules (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
- Keywords
- liquiritigenin, tau protein, Alzheimer's disease, amyloid fibril formation inhibition, neurotoxicity, flavanones, reactive oxygen species, caspase-3, catalase, SH-SY5Y cells, Congo red binding, hydrophobic patch
- MeSH terms
- Anilino Naphthalenesulfonates, Catalase, Cell Line, Circular Dichroism, Humans, Neurons, Spectrometry, Fluorescence, tau Proteins, Reactive Oxygen Species, Neuroprotective Agents, Flavanones, Microscopy, Electron, Transmission, Cell Proliferation, Benzothiazoles, Caspase 3, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review